Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    INBRX-!09 on the Fast Track for Metastatic Conventional Chondrosarcoma Patients

    Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients

    Registration-enabling study expected to begin dosing in the second or third quarter of this year

    Inhibrx, Inc. logo (PRNewsfoto/Inhibrx, Inc.)